| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.39 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.002 |